Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

New RIPK1 inhibitors presented by National Institute of Pharmaceutical R&D

Nov. 30, 2021

Oncostatin M targeting as approach for treating inflammatory pruritus

Nov. 30, 2021

IL-17A/IL-17RA interaction modulators patented by Janssen Pharmaceutica

Nov. 25, 2021

Chinese researchers synthesize new phosphodiesterase PDE4 inhibitors

Nov. 19, 2021

Vyne reports preclinical data on effect of VYN-201 on skin healing and repair

Nov. 5, 2021

Studies show that psoriasis is more than skin-deep

Nov. 2, 2021

Vyne reports findings with BET inhibitor VYN-201 in animal model and ex vivo human tissue study

Oct. 27, 2021

Titan Pharmaceuticals and MUSC enter research agreement on kappa-opioid receptor agonists

Oct. 14, 2021

Development of cell-penetrating asymmetric siRNAs for treating androgenetic alopecia

Oct. 8, 2021

IL-4 and IL-13 drive atopic dermatitis pathology by regulating sex steroid hormone synthesis

Oct. 4, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...